How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/secondary-infection-of-surgical-wounds-caused-by-mrsa.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Secondary infection of surgical wounds caused by MRSA — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Secondary infection of surgical wounds caused by MRSA (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Secondary infection of surgical wounds caused by MRSA, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Cubicin	Daptomycin	Baxter	lipopeptide antibacterial		2003-01-01
Cubicin	Cubicin	Clinical Alliance for Research & Education - Infectious Diseases, LLC.		Outer membrane porin protein OmpD
DAPT	DAPT	Baxter Hlthcare Corp		Outer membrane porin protein OmpD

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Baxter · 1 drug in Secondary infection of surgical wounds caused by MRSA
Baxter Hlthcare Corp · 1 drug in Secondary infection of surgical wounds caused by MRSA
Clinical Alliance for Research & Education - Infectious Diseases, LLC. · 1 drug in Secondary infection of surgical wounds caused by MRSA

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Secondary infection of surgical wounds caused by MRSA:

Cite this brief

Drug Landscape (2026). Secondary infection of surgical wounds caused by MRSA — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/secondary-infection-of-surgical-wounds-caused-by-mrsa. Accessed 2026-06-10.

Secondary infection of surgical wounds caused by MRSA full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing